Results
Filtros
More than 500 companies offer cannabis products to Brazil through importation; products now exceed 600
Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Rio Grande do Sul to host 3rd Gaúcho Medicinal Cannabis and Industrial Hemp Symposium in December
Event brings together experts from ex-Anvisa, Embrapa, and state government to discuss from medical prescription to agricultural potential of hemp
Government asks STJ for additional 180 days to deliver regulation on cannabis cultivation
Ministry of Health and Anvisa claim technical complexity and propose a new schedule that extends until March 2026 to define the rules
Countdown: government has until September 30th to publish regulation on cannabis cultivation
Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan
Deusa Cast discusses advances and obstacles of Medicinal Cannabis in Brazil
Featuring Larissa Meneghel (lawyer and former Anvisa public servant), Paula Scanapieco (Mile Express), and Juliana Sousa (lawyer specialized in customs and criminal law)
Government has five days to comment on regulation of cannabis cultivation, determined by STJ
STJ Minister demands Union and Anvisa to execute the Action Plan for the medicinal cultivation of the plant
Trump redefines hemp market: between pharmaceutical regulation and federal revenue
Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control
STJ Minister sets final deadline for regulation of cannabis cultivation: March 2026
Minister Regina Helena Costa states that this will be the last extension and orders Anvisa to report compliance with each intermediate step of the plan
DNA requests STJ authorization for regulatory sandbox after delay in hemp regulation
Company demands urgent measures in face of new missed deadlines by the government and Anvisa and proposes experimental environment under judicial supervision
The path of cannabis in animal well-being is made of science, empathy, and new hopes
The use of medicinal cannabis in pets has been growing in Brazil since Anvisa's authorization in 2024, bringing relief for chronic pain, epilepsy, and anxiety in animals, and renewed hope for pet owners
Professor Advocates for Inclusion of Physical Therapists in Cannabis-Based Treatment
COFFITO Ruling No. 735/2024 authorizes physical therapists with specific training to prescribe medications and supplies; however, Anvisa recognizes only doctors and dentists as prescribers of cannabis for medicinal purposes
Embrapa secures R$ 13.2 million from Finep for research and projects scientific cultivation to begin in 2026
12/11/2025The historic investment from the Financier of Studies and Projects (Finep) will finance cutting-edge structures in two regions of the country. The approval, combined with recent authorizations from Anvisa, boosts the development of the scientific bases of the "CBD Brazil" project with the central goal of reducing the costs of medicinal products in Brazil, subsidizing the national production chain
Regulation of cannabis cultivation is the focus of Abiquifi's mission to Colombia, which started today in Bogotá
Brazilian delegation led by Abiquifi participates in a mission to Colombia to exchange experiences on the regulation of cannabis cultivation, with representatives from MAPA, Anvisa, Embrapa, and major pharmaceutical industries
IPT invests in new laboratory and aims at flower and extract analysis
Expansion of the institute in the sector, however, depends on new authorizations from Anvisa for the quality control of plant-based raw materials
Cannabis in the Treatment of Skin Diseases: 3 Science-Backed Benefits
Studies show efficacy of cannabinoids in controlling inflammation, acne, and itching, while Anvisa evaluates expanding regulations for topical products
RDC-327 and Cannabis Research: Lawyer Explains Proposal to Extend Deadline for Clinical Studies
On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa
CFF advocates for magistral manipulation amid changes in Cannabis regulation
Entity reinforces that personalized preparations are essential when industrialized products do not meet clinical needs